FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Yasuhiro Kawagoe

Research Profile

Chemicals & Drugs

Procedures

Disorders

Concepts & Ideas

Co-author Network

Publications

TOP 3
Tsukasa Nakamura; Yoshihiko Ueda; Shingo Yamada; Yasuhiro Kawagoe; Hikaru Koide
Hemoperfusion treatment in a septic shock patient with autosomal dominant polycystic kidney disease and increased HMGB1 protein levels.
Tsukasa Nakamura; Eiichi Sato; Nobuharu Fujiwara; Yasuhiro Kawagoe; Yoshihiko Ueda; Takeshi Sugaya; Shoichi Yamagishi; Shingo Yamada; Hikaru Koide
Comparative effects of benidipine and amlodipine on proteinuria, urinary 8-OHdG, urinary L-FABP, and inflammatory and atherosclerosis markers in early-stage chronic kidney disease.
Tsukasa Nakamura; Nobuharu Fujiwara; Eiichi Sato; Yasuhiro Kawagoe; Yoshihiko Ueda; Shingo Yamada; Hikaru Koide
Effect of polymyxin B-immobilized fiber hemoperfusion on serum high mobility group box-1 protein levels and oxidative stress in patients with acute respiratory distress syndrome.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Yasuhiro Kawagoe (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Tsukasa Nakamura; Yoshihiko Ueda; Shingo Yamada; Yasuhiro Kawagoe; Hikaru Koide
Hemoperfusion treatment in a septic shock patient with autosomal dominant polycystic kidney disease and increased HMGB1 protein levels.
Blood purification 2011;32(2):139-42.
2010: Tsukasa Nakamura; Eiichi Sato; Nobuharu Fujiwara; Yasuhiro Kawagoe; Yoshihiko Ueda; Takeshi Sugaya; Shoichi Yamagishi; Shingo Yamada; Hikaru Koide
Comparative effects of benidipine and amlodipine on proteinuria, urinary 8-OHdG, urinary L-FABP, and inflammatory and atherosclerosis markers in early-stage chronic kidney disease.
The American journal of the medical sciences 2010;339(2):157-63.
2009: Tsukasa Nakamura; Nobuharu Fujiwara; Eiichi Sato; Yasuhiro Kawagoe; Yoshihiko Ueda; Shingo Yamada; Hikaru Koide
Effect of polymyxin B-immobilized fiber hemoperfusion on serum high mobility group box-1 protein levels and oxidative stress in patients with acute respiratory distress syndrome.
ASAIO journal (American Society for Artificial Internal Organs : 1992) 2009;55(4):395-9.
2008: Tsukasa Nakamura; Teruo Inoue; takeshi sugaya; Yasuhiro Kawagoe; Tsukasa Suzuki; Yoshihiko Ueda; Koichi Node
Renoprotective effect of telmisartan in patients with chronic kidney disease.
Clinical and experimental hypertension (New York, N.Y. : 1993) 2008;30(7):662-72.
2008: Tsukasa Nakamura; Teruo Inoue; Tsukasa Suzuki; Yasuhiro Kawagoe; Yoshihiko Ueda; Hikaru Koide; Koichi Node
Comparison of renal and vascular protective effects between telmisartan and amlodipine in hypertensive patients with chronic kidney disease with mild renal insufficiency.
Hypertension research : official journal of the Japanese Society of Hypertension 2008;31(5):841-50.
2008: Tsukasa Nakamura; Tsukasa Suzuki; Yasuhiro Kawagoe; Hikaru Koide
Polymyxin B-immobilized fiber hemoperfusion attenuates increased plasma atrial natriuretic peptide and brain natriuretic Peptide levels in patients with septic shock.
ASAIO journal (American Society for Artificial Internal Organs : 1992) 2008;54(2):210-3.
2007: Tsukasa Nakamura; Teruo Inoue; takeshi sugaya; Yasuhiro Kawagoe; Tsukasa Suzuki; Yoshihiko Ueda; Hikaru Koide; Koichi Node
Beneficial effects of olmesartan and temocapril on urinary liver-type fatty acid-binding protein levels in normotensive patients with immunoglobin A nephropathy.
American journal of hypertension 2007;20(11):1195-201.
2007: Tsukasa Nakamura; Yasuhiro Kawagoe; Tsukasa Suzuki; Hisataka Shoji; Yoshihiko Ueda; Hikaru Koide
Polymyxin B-immobilized fiber hemoperfusion with the PMX-05R column in elderly patients suffering from septic shock.
The American journal of the medical sciences 2007;334(4):244-7.
2006: Tsukasa Nakamura; takeshi sugaya; Yasuhiro Kawagoe; Yoshihiko Ueda; Hikaru Koide
Effect of pioglitazone on urinary liver-type fatty acid-binding protein concentrations in diabetes patients with microalbuminuria.
Diabetes/metabolism research and reviews 2006;22(5):385-9.
2006: Tsukasa Nakamura; takeshi sugaya; Yasuhiro Kawagoe; Yoshihiko Ueda; Shiwori Osada; Hikaru Koide
Urinary liver-type fatty acid-binding protein levels for differential diagnosis of idiopathic focal glomerulosclerosis and minor glomerular abnormalities and effect of low-density lipoprotein apheresis.
Clinical nephrology 2006;65(1):1-6.
2005: Tsukasa Nakamura; takeshi sugaya; Yasuhiro Kawagoe; Yoshihiko Ueda; Shiwori Osada; Hikaru Koide
Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy.
Diabetes care 2005;28(11):2728-32.
2005: Tsukasa Nakamura; takeshi sugaya; Yasuhiro Kawagoe; Yoshihiko Ueda; Shiwori Osada; Hikaru Koide
Candesartan reduces urinary fatty acid-binding protein excretion in patients with autosomal dominant polycystic kidney disease.
The American journal of the medical sciences 2005;330(4):161-5.
2005: Tsukasa Nakamura; Yasuhiro Kawagoe; Yoshihiko Ueda; Hikaru Koide
Polymyxin B-immobilized fiber hemoperfusion with low priming volume in an elderly septic shock patient with marked endotoxemia.
ASAIO journal (American Society for Artificial Internal Organs : 1992) 2005;51(4):482-4.
2005: Tsukasa Nakamura; Yasuhiro Kawagoe; Yoshihiko Ueda; Hikaru Koide
Polymyxin B-immobilized fiber hemoperfusion in a patient with active ulcerative colitis.
ASAIO journal (American Society for Artificial Internal Organs : 1992) 2005;51(4):471-3.
2005: Tsukasa Nakamura; Yasuhiro Kawagoe; Tsukasa Suzuki; Hisataka Shoji; Yoshihiko Ueda; Noriyoshi Kobayashi; Hikaru Koide
Changes in plasma interleukin-18 by direct hemoperfusion with polymyxin B-immobilized fiber in patients with septic shock.
Blood purification 2005;23(6):417-20.
2005: Tsukasa Nakamura; Yasuhiro Kawagoe; Hiroshi Ogawa; Yoshihiko Ueda; Masanori Hara; Noriaki Shimada; Isao Ebihara; Hikaru Koide
Effect of low-density lipoprotein apheresis on urinary protein and podocyte excretion in patients with nephrotic syndrome due to diabetic nephropathy.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2005;45(1):48-53.
2005: Tsukasa Nakamura; Yasuhiro Kawagoe; Takaharu Matsuda; Yoshihiko Ueda; Isao Ebihara; Hikaru Koide
Silent cerebral infarction in patients with type 2 diabetic nephropathy. Effects of antiplatelet drug dilazep dihydrochloride.
Diabetes/metabolism research and reviews 2005;21(1):39-43.
2004: Tsukasa Nakamura; Yasuhiro Kawagoe; Takaharu Matsuda; Yoshihiko Ueda; Hikaru Koide
Effects of polymyxin B immobilized fiber on urinary N-acetyl-beta-glucosaminidase in patients with severe sepsis.
ASAIO journal (American Society for Artificial Internal Organs : 1992) 2004;50(6):563-7.
2004: Tsukasa Nakamura; Takaharu Matsuda; Yasuhiro Kawagoe; Hiroshi Ogawa; Yutaka Takahashi; Keiko Sekizuka; Hikaru Koide
Effect of pioglitazone on carotid intima-media thickness and arterial stiffness in type 2 diabetic nephropathy patients.
Metabolism: clinical and experimental 2004;53(10):1382-6.
2004: Tsukasa Nakamura; Yasuhiro Kawagoe; Yoshihiko Ueda; Hikaru Koide
Antineutrophil cytoplasmic autoantibody-associated rapidly progressive glomerulonephritis in a patient with primary biliary cirrhosis.
The American journal of the medical sciences 2004;328(3):176-9.
2004: Tsukasa Nakamura; Yasuhiro Kawagoe; Takaharu Matsuda; Hikaru Koide
Effect of polymyxin B-immobilized fiber on bone resorption in patients with sepsis.
Intensive care medicine 2004;30(9):1838-41.
2004: Tsukasa Nakamura; Takaharu Matsuda; Yasuhiro Kawagoe; Yoshihiko Ueda; Isao Ebihara; Hikaru Koide
Plasmapheresis with immunosuppressive therapy vs immunosuppressive therapy alone for rapidly progressive anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004;19(7):1935-7.
2004: Tsukasa Nakamura; Yasuhiro Kawagoe; Takaharu Matsuda; Yoshihiko Ueda; Hikaru Koide
Low-density lipoprotein apheresis in a patient with arteriosclerosis obliterans and light chain deposition disease.
Clinical nephrology 2004;61(6):429-33.
2004: Tsukasa Nakamura; Yasuhiro Kawagoe; Takaharu Matsuda; Akiko Ueda; Yoshihiko Ueda; Yutaka Takahashi; Araki Tanaka; Hikaru Koide
Effect of granulocyte and monocyte adsorption apheresis on urinary albumin excretion and plasma endothelin-1 concentration in patients with active ulcerative colitis.
Blood purification 2004;22(6):499-504.
2004: Tsukasa Nakamura; Yasuhiro Kawagoe; Takaharu Matsuda; Hisataka Shoji; Yoshihiko Ueda; Naoaki Tamura; Isao Ebihara; Hikaru Koide
Effect of polymyxin B-immobilized fiber on blood metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 levels in acute respiratory distress syndrome patients.
Blood purification 2004;22(3):256-60.
2004: Tsukasa Nakamura; Yasuhiro Kawagoe; Yoshihiko Ueda; Isao Ebihara; Hikaru Koide
Effects of oral adsorbent AST-120 in patients with chronic renal failure with or without diabetes.
Renal failure 2004;26(1):99-101.
2004: Tsukasa Nakamura; Yasuhiro Kawagoe; Takaharu Matsuda; Yoshihiko Ueda; Noriaki Shimada; Isao Ebihara; Hikaru Koide
Oral ADSORBENT AST-120 decreases carotid intima-media thickness and arterial stiffness in patients with chronic renal failure.
Kidney & blood pressure research 2004;27(2):121-6.
2003: Tsukasa Nakamura; Yasuhiro Kawagoe; Takaharu Matsuda; Isao Ebihara; Hikaru Koide
Effects of polymyxin B-immobilized fiber hemoperfusion on amino acid imbalance in septic encephalopathy.
Blood purification 2003;21(4-5):282-6.
2003: Tsukasa Nakamura; Yasuhiro Kawagoe; Takaharu Matsuda; Yutaka Takahashi; Keiko Sekizuka; Isao Ebihara; Hikaru Koide
Effects of LDL apheresis and vitamin E-modified membrane on carotid atherosclerosis in hemodialyzed patients with arteriosclerosis obliterans.
Kidney & blood pressure research 2003;26(3):185-91.